Gel Documentation Systems Market To Rear Excessive Growth By 2023

Gel Documentation Systems Market Overview

The global gel documentation systems market was valued at USD 245 Mn and is expected to expand at a CAGR of 3.6% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in a detailed study. 

Infectious diseases and genetic disorders are on the rise currently. Gel documentation systems find potential application in the molecular biology which includes nucleic acid isolation or amplification for molecular cloning techniques, gene silencing, gene modulation, and gene expression. 

Rise in genomic research and a growing emphasis on personalized medicine and synthetic biology is also a key factor enhancing the global gel documentation systems market growth. Gel documentation systems provide flexibility and ease of use in imaging nucleic acid and protein gels due to which they are gaining traction among research studies. The rise in a number of research laboratories, diagnostic centers, clinical and medical institutions have contributed positively to the growth of the global gel documentation systems market. 

Gel documentation technology has come a long way since they were first introduced and technological advancements have made the technology much more superior and advanced. New gel documentation systems are compatible with Windows and Mac operating systems and come with complete software. Furthermore, these systems have evolved in terms of affordability, reliability, functionality, and ease of use which augments the growth of the market. 

On the flip side, high costs associated with gel documentation systems is likely to restrain the growth of the global gel documentation systems market. Most commercial gel documentation systems available in the market are not affordable in developing countries where the growth of the market is imopeded due to price sensitivity.

Gel Documentation Systems Market Segmentation

The global gel documentation systems market has been segmented based on product, detection techniques, application, and end user. 

By product, the global gel documentation systems market has been segmented into accessories, instruments, and software. The instrument segment has been further segmented into film gel documentation instruments and digital gel documentation instruments. Increasing R&D activities within the biotechnology and pharmaceutical industries boost the growth of the instruments segment which accounts for the maximum share of the market. 

By detection technique, the global gel documentation systems market has been segmented into ultraviolet, chemiluminescence, and fluorescence. 

By application, the global gel documentation systems market has been segmented into protein quantification, nucleic acid quantification, and others. 

By end user, the global gel documentation systems market has been segmented into pharmaceutical & biotechnology companies, diagnostic laboratories, academic institutes & research centers, and others.

Gel Documentation Systems Market Regional Analysis

By region, the global gel documentation systems market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA). 

The Americas account for the maximum share of the global gel documentation systems market. Expansion of clinical R&D budgets by biotechnology and pharmaceutical companies accompanied by government support in the form of R&D grants boosts the growth of the gel documentation systems market. In addition, the region is a frontrunner in the adoption of advanced technology within the healthcare sector which acts as a plus for the growth of the market. 

Europe commands the second position in the global gel documentation systems market. Robust academic & research base and availability of funds for research can be credited for the growth of the Europe market. 

Higher emphasis on biomedical and biotechnology sector and rise in a number of proteomic and genomic studies have helped APAC establish itself as a significant market for gel documentation systems. APAC is slated to register the highest CAGR over the forecast period. 

The Middle East holds the major share of the MEA gel documentation systems market due to the improvement of the healthcare sector in the region. The Africa market is likely to showcase limited growth due to low healthcare penetration.

Gel Documentation Systems Market Competitive Landscape

GE Healthcare, Azure Biosystems, Scientific Digital Imaging Plc., Thermo Fisher Scientific, LI-COR Biosciences, Bio-Techne, Endress + Hauser Management AG, Cleaver Scientific, Bio-Rad Laboratories, Inc., Vilber Lourmat are the notable players in the global gel documentation systems market.

Obtain Premium Research Report Details @

Gel Documentation Systems Industry Updates

In February 2018, Syngene, Asia’s largest contract research & manufacturing organization, introduced a new gel documentation system, the InGenius3. The new gel doc system features integrated to a compact light-tight darkroom, and overhead Epi LED white lighting for perfect gel positioning and a 3 million pixel CCD camera.

Angina Market Projected To Discern Stable Expansion During 2018 – 2023

Angina Market Highlights

The rising prevalence of angina and coronary heart diseases, growing healthcare expenditure, and increasing geriatric and obese population are expected to drive the global angina market, during the forecast period. However, low per capita healthcare expenditure and high cost for therapeutic procedures such as coronary bypass surgery restraints the market growth.

Angina Market Key Players

Some of the major market players in the global angina market are Anthera (U.S.), Taxus Cardium (U.S.), Astellas Pharma (Japan), Sanofi (France), Bayer AG (Germany), Merck & Co., Inc. (U.S.), Torrent Pharmaceuticals Limited (India), Huya Bioscience International (U.S.), Viromed Co. Ltd. (South Korea), Baxter (U.S.), and others.

Angina Market Segmentation

The global angina market is segmented on the basis of type, diagnosis, treatment, and end-user.

On the basis of type, the market is segmented into angina pectoris, unstable angina, prinzmetal angina, and others. On the basis of diagnosis, the market is categorized into imaging, blood test, stress test, and others. The imaging segment is sub-segmented into electrocardiogram, chest X-ray, cardiac computerized tomography scan, cardiac MRI, and others. The blood test segment is sub-segmented into cholesterol test, low-density lipoprotein test, triglycerides test, and others. On the basis of treatment, the market is segmented into lifestyle changes, medications, angioplasty and stenting, coronary bypass surgery, and others. The medication segment is sub-segmented into aspirin, clot-preventing drugs, statins, ranolazine, and others. The clot-preventing drugs segment is further segmented into clopidogrel, prasugrel, and others. On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic centers, academic institutes, and others.

Angina Market Regional Analysis

America dominates the global angina market. This can be attributed to the presence of a well-developed healthcare sector and a huge patient population for coronary heart diseases. Additionally, key players such as Merck & Co., Inc. and Baxter within the region fuel the market growth. Europe stands second in the global market for angina. Availability of funds for research, growing number of obese and patient population, and the presence of developed economies such as France, Italy, and Germany within the region are the major drivers for the market growth within the region.

Access Report Details @

Asia Pacific is estimated to be the fastest growing region, owing to the presence of developing economies such as India and China and a developing healthcare sector. Moreover, factors such as rising healthcare expenditure and favorable government policies are expected to boost the market growth during the forecast period. The Middle East and Africa hold the least share in the market. This can be attributed to the presence of poor economies, stringent government policies, and low per capita healthcare expenditure, especially within the African region. A majority of the market of the region is held by the Middle East.

Impact Analysis of COVID-19 on Vagal Nerve Stimulation (VNS) Market Analysis 2021 by Technology, Future Growth, Revenue Analysis, Demand And Forecast To 2023

Vagal nerve stimulation (VNS) is a method used for delivering electrical impulses to the vagus nerve. The vagus nerve acts as a translator between the gut and the brain. The method involves the implantation of a device under the clavicle with lead wires being wrapped around the vagus nerve for sending out electrical impulses. The global vagal nerve stimulation market report by Market Research Future (MRFR) compiled by reputed analysts enumerates drivers, challenges, and opportunities in a comprehensive manner.

Vagal Nerve Stimulation (VNS) Market Overview

The global vagal nerve stimulation market size is expected to balloon at 8.68% CAGR during the forecast period (2017-2023). Rise in number of neurological disorders such as epilepsy, depression, migraine, and others is one of the biggest drivers of the market. According to the World Health Organization (WHO), neurological disorders accounted for 4.5-11% of all diseases in low-income and mid-income economies. High need for better treatment techniques and influx of capital into research and development by pharmaceutical and biotechnology firms can create opportunity of growth for the market.

Development of novel technologies for epilepsy treatment and favorable reimbursement policies proposed by governments in alliance with health coverage companies can persuade patients for the treatment. Research for the management and treatment of muscle function and organ disorders is likely to widen the scope of VNS manufacturers in the market.

Paucity of skilled surgeons and high costs of neurostimulation devices can pose a challenge to the market growth. Side-effects of cardiac arrest and probability of triggering a stroke can lead to hesitancy among doctors for prescribing the treatment.

Vagal Nerve Stimulation (VNS) Market Segmentation

The global vagal nerve stimulation market is segmented by product, application, and end-user.

By product, it is segmented into external VNS devices and implantable VNS devices.

By application, it is segmented into migraine, epilepsy, depression, and others.

By end-user, it is segmented into ambulatory surgical centers, hospitals, and others.

Vagal Nerve Stimulation (VNS) Market Regional Analysis

Asia Pacific (APAC), the Americas, Europe, and the Middle East & Africa (MEA) are major regions discussed in the global vagal nerve stimulation market.

The Americas accounted for 43% market share in 2016. Rising government support for research and development into neurological disorders, high healthcare spending, and sophisticated healthcare infrastructure and framework for major manufacturers to enter the region can bode well for the market growth. Presence of large players as well as their increased capacity to invest in sufficient amount of capital can encourage the market proliferation during the forecast period.

Europe holds the second position in the market standings due to availability of sufficient funds for research and development and rise in government support. On the other hand, the APAC region has latent potential for growth due to economies of China, South Korea, Japan, and India. The increased healthcare budget of economies, large patient pool, and development of neurostimulation technology are factors which can boost the regional market growth.

Lastly, the MEA region can offer limited returns growth and revenue-wise due to insufficient funding by governments and a paucity of healthcare infrastructure.

Obtain Premium Research Report Details @

Vagal Nerve Stimulation (VNS) Market Competition Outlook

LivaNova PLC, ElectroCore Medical LLC, EnteroMedics Inc., NeuroMetrix, Inc., Boston Scientific Corporation, Inspire Medical Systems, Inc., Cyberonics, Inc., ImThera Medical, and others are prominent names currently operational in the global vagal nerve stimulation market. Collaborations between medical device manufacturers and hospitals for measuring the efficacy of devices is likely to result in faster development of effective devices. For instance, the Massachusetts General Hospital decided to collaborate with electroCore, Inc., for attaining sufficient clinical trial data for gauging the performance of VNS Therapy for treatment of depression, migraine, and other neurological disorders.

Recently, LivaNova PLC was celebrating the success of its proprietary VNS Therapy System by proving to be effective for the treatment of drug-resistant epilepsy (DRE).

Impact Analysis of COVID-19 on Carcinoembryonic Antigen Market Analysis 2021 by Emerging Trends, Top Companies, Future Growth, Revenue Outlook, Demand Forecast To 2025

Carcinoembryonic Antigen Market Highlights

Carcinoembryogenic antigen (CEA) is a group of glycoproteins which are produced during the fetal developmental stages by gastrointestinal tissues. CEA is responsible for cell adhesion. Healthy adults do not have CEA concentrations. However, smoking and certain medical conditions such as colorectal cancer, breast cancer etc. can mark the presence of CEA in the body. Thus, CEA based diagnostic assays are used for the detection of such cancers and to check the treatment efficiency during the therapeutic period by a physician.

In 2017, studies of the NCBI suggested that the global burden of colorectal cancer will increase by 60%, leading to 2.2 million new cancer cases and 1.1 million deaths by 2030. This will increase the colorectal cancer diagnostic demands, thereby propelling the Carcinoembryonic Antigen Market Growth.

Increasing prevalence of cancer, rising healthcare expenditures, and developing diagnostic technologies will boost the global market during the forecast period. However, risk of infection and hematoma, lack of awareness and medical services in the developing countries will restrain the market growth during the assessment period.

Carcinoembryonic Antigen Market Players

Some of key players profiled in the report are Lee BioSolutions, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated., Correlogic Systems, Inc, Genway Biotech, Inc., Abbott., RayBiotech, Inc., Abcam plc., Biocare Medical, LLC, and Biocare Medical, LLC.

Carcinoembryonic Antigen Market Segmentation

The global carcinoembryonic antigen market has been segmented on the basis of application, sampling, and end user.

Based on application, the market has been segmented into colorectal, pancreatic, breast, lung cancer, and others.  

Based on sampling, the market has been segmented into antecubital, peritoneal, pleural, serebrospinal, and others.

Based on the end users, the market has been segmented into hospitals, diagnostic centers, research centers, and others.

Carcinoembryonic Antigen Market Regional Analysis

The Americas account for the largest share in the carcinoembryogenic antigen market. The Americas mainly include countries like the U.S. and Canada. Increasing prevalence of cancer and high healthcare expenditures within the region will boost the market growth over the assessment period.

Europe is the second highest revenue generating region in the global carcinoembryogenic antigen market. Increasing prevalence of cancer, fast adoption of new technologies and presence of developed countries like Germany and U.K within the region will boost the market growth during the forecasted period.

Access Complete Report @

On account of the developing medical infrastructure, rising healthcare expenditure, and increasing government initiatives, Asia Pacific region is expected to grow the fastest.

The Middle East & Africa is expected to grow slower than the global average. The Middle Eastern countries, for instance, UAE and Saudi Arabia dominates the market due to high income and the government support to improve public health.

Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Carcinoembryogenic Antigen Market” Research Report – Forecast till 2023.

Chondroplasty Market Overview By Share, Size, Industry Players, Revenue And Product Demand Forecast Till 2023

Chondroplasty Market Highlights:

Chondroplasty is a surgery of damaged cartilage with an aim to reduce friction in joints such as knee joint. In healthy condition articular cartilage which covers the end of the bones that form the joint is smooth and provides low friction surface for the joint structures. However in conditions such as arthritis, trauma, injuries etc. it becomes rough and damaged causing pain and swelling. Joint cartilage once damaged naturally heals poorly in most cases. Chondroplasty is performed to decrease complications, risks, and recovery time. The purpose of chondroplasty is to remove away the damaged joint surface.

The recent developments in the chondroplasty treatment includes development of radio frequency chondroplasty which uses radio frequency waves to fill cracks and wedges in the cartilage structure and also to stimulate growth. There is also an increasing trend towards miniaturization of devices. Development of alloys have advanced the shavers and made them more efficient to ensure less trauma to the tissue being treated.

The drivers for chondroplasty market are increasing geriatric population, growing screening for joint and orthopaedic defects, rising number of accidents and trauma cases, growing sports culture, rising awareness and growing income of people.

The market restraints are risks associated with surgery such as bleeding, pain, infection, poor healing in some cases, cost considerations etc.

Global Chondroplasty Market Players

Key players profiled in the report are B. Braun Melsungen AG, NuOrtho Surgical, Inc., Zimmer Biomet Holdings Inc., Smith & Nephew plc, Nebula Inc., Gpcmedical, Osiris Therapeutics, Inc., Sklar Surgical Instruments, Stryker Corporation and others.

Chondroplasty Market Segmentation

The global chondroplasty market has been segmented on the basis of types, anatomy, instruments and end users.

Based on types, the market has been segmented as radiofrequency ablation chondroplasty, abrasion chondroplasty, atellar chondroplasty, meniscal repair, tissue removal, and others.

Based on anatomy, the market has been segmented as knee, shoulder, hip, and others.

Based on instruments, the market has been segmented as shavers, RF devices, arthroscope and others.

Based on the end users, the market has been segmented as hospitals & orthopedic clinics, academic and research and others.

Access Complete Report @

Chondroplasty Market Regional Analysis

The Americas account for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new instruments and surgical techniques in the US drives the chondroplasty market. The good reimbursement scenario and the greater awareness in the developed regions drive the market.
Europe is the second largest market in the world due to high income and healthcare penetration.

Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.
Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.

Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Chondroplasty Market” Research Report – Forecast till 2023.

Bioactive Fillings Market 2021: Drivers, Restraints, Opportunities, Threats, Trends, Applications, Growth Analysis and Forecast To 2023

Global Bioactive Fillings Market Overview

Surface reactive glass-ceramic biomaterials are called bioactive fillings. These fillings have a compatible interaction with biological tissues. And thus, have a high application as an implant material in the human body to repair and reverse diseases or permanently scarred tissue. Bioactive fillings react to biological tissues in two phases. Firstly, the alkali metal ions are replaced with hydrogen ions. In the second phase, the Si-O-Si bonds in silica matrix witness hydrolysis, developing a gel-like layer on the surface, which is rich in Si-O-H groups.

The global bioactive fillings market size is anticipated to ascend at a 9.2% CAGR, garnering a valuation of 6.8 billion by 2023. Various driving factors include rising demand in tissue implants owing to proliferation in population, and fast-paced technological innovations in the bioactive fillings sector. Additionally, a strong emphasis on restorative procedures and high success rates of bioactive fillings treatments are anticipated to contribute heavily to the growth witnessed by the global bioactive fillings market.

On the other hand, some factors are likely to slow down and hinder growth in the bioactive fillings market. Such factors include lower fracture resistance, inadequate load-bearing capacity, lack of proper mechanical strength, costly treatments, and possible toxicity.

Bioactive Fillings Market Segmental Analysis

The global bioactive fillings market has been studied by Market Research Future (MRFR), for various segments based on material, application, end-user, and region. Based on material, the global bioactive fillings market is segmented into calcium oxide based, silicon dioxide based, sodium oxide based, and phosphorus pentoxide based. Based on applications, the global bioactive fillings market is segmented into dental, tissue engineering, and orthopedic. Based on end-user, the global bioactive fillings market is segmented into research & academics, dental hospitals, and orthopedic hospitals.

Bioactive Fillings Market Regional Analysis

The global bioactive fillings market is regionally segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa. Among these regional segments, the Americas are anticipated to hold the largest share in the global bioactive fillings market. This market domination can be attributed to high healthcare spending noted in the region, especially in the U.S. and Canada. Further, the rising number of restorative procedures in the U.S. and Canada are anticipated to drive the global bioactive fillings market. High concentration of world-class hospitals in the developed countries of the region, along with favorable reimbursement schemes, are both credible to lucrative growth in the regional bioactive fillings market.

Europe is estimated to follow the Americas and garner the second largest share in the global bioactive fillings market over the assessment period. A growing medical devices industry and mushrooming healthcare sector in the region are some factors influencing an ascension in the global bioactive fillings market. Germany and France are estimated to spearhead the country-specific bioactive fillings market. Germany is projected to showcase the fastest growth over the forecast period due to the country having the biggest medical devices industry residing and a big research base.

Asia Pacific is estimated to grow at a rapid pace during the assessment period. India and China are projected to lead the global bioactive fillings market owing to a fast-paced growth observed in the healthcare sector and a wide gap in the demand and supply during the forecast period. Malaysia, India, and China are anticipated to lead the country-specific bioactive fillings market. A burgeoning penetration of the healthcare industry in the Asia Pacific is another factor attributed to the growth of the bioactive fillings market.

Gulf countries like the UAE and Saudi Arabia are assessed to lead the bioactive fillings market in the Middle East & Africa. Other than these, Kuwait, Egypt, Jordan, and Iran are some other countries witnessing substantial growth in the global bioactive fillings market by the end of 2023. Countries in Africa are expected to showcase sluggish growth due to poor economic and political conditions and lack of development in the healthcare sector.

Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @

Bioactive Fillings Market Key Players

The report published on bioactive fillings market has profiling of many prominent market players including Septodont, Inc., DePuy Synthes, Medtronic, Stryker, Zimmer Biomet, SCHOTT AG, Aap Implantate AG, GNI GROUP LTD., Arthrex, Inc., and Baxter.

Bioactive Fillings Industry Update

Jan 2019: Scientists from the National Centre of Nanoscience and Nanotechnology, University of Madras have developed a new technique that can produce bioactive dental filling materials that cut down the time taken for the formation of new bone tissues. These scientists have synthesized a crystallization induced, strontium-based nano-sized materials by using a sol-gel assisted microwave method.

Electrotherapy Market 2018 – 2023: Company Profiles, Regional Study, Business Trends, Industry Segments, Landscape and Demand

Electrotherapy Market– Overview

The rise in the acceptance of physiotherapy for treating various ailments has also bolstered the demand for electrotherapy globally. Market reports linked to the medical device industry have been made available by Market Research Future which creates reports on other industry verticals that outlines the current market scenarios. The market is anticipated to expand with a 4.2% CAGR while achieving revenues totaling US$ 1119.1 million by the end of the forecast period.

The upsurge in the number of cases related to soft tissue injuries and muscles impairments are increasing the demand for electrotherapy devices. The electrotherapy market size is expected to gain substantial traction due to the increased inclination of customers towards drug-free methods of treatment. Furthermore, the awareness of the benefits of electrotherapy is anticipated to provide more avenues for growth in the upcoming forecast period.

Electrotherapy Market Segmental Analysis

The electrotherapy market has been segmented on the basis of type, devices, application, and region. On the basis of type, the market is segmented into Interferential, Extracorporeal Shock Wave Therapy, Magnetic Field Therapy (Pulsed Electro-Magnetic Field Energy, Constant Energy Magnets), Transcutaneous Electrical Nerve Stimulation (TENS) Therapy (Intense TENS, Conventional TENS, Acupuncture-like TENS (AL-TENS)), Ultrasound Therapy, and others. The segmentation on the basis of devices comprises of Electronic Muscle Stimulator (EMS), High Voltage Pulsed Galvanic Stimulator (HVPGS), Transcutaneous Electrical Neural Stimulator (TENS), Interferential Stimulator (IF), Microcurrent Stimulator (MC) or Microcurrent Electrical Neuromuscular Stimulator (MENS), among others. The segmentation of the electrotherapy market on application basis comprises of orthopedics, cardiology, urology, pain management (chronic fatigue, chronic pain, migraine headaches, diabetic nerve pain, wound healing, stimulating bone growth), Chronic and Acute Edema among others. The regions covered in the market are Europe, North America, Asia Pacific, Africa, and the Middle East.

Electrotherapy Market Regional Analysis 

The regional analysis of the electrotherapy market comprises of regions such as North America, Europe, Asia Pacific, Africa, and the Middle East. The North American region is the major market for electrotherapy. In the North America region, the US controls a major market share while the European market is the next major region in the market. The growth rate is relatively higher in west European countries. Conversely, the Asia Pacific region is a rapidly growing market and is anticipated to control the market by the year 2023. The Middle East and African region are expected to have restrained growth in the market owing to a low-level awareness of the devices and treatment. 

Access Report @

Electrotherapy Market Competitive Analysis

The plan formulation process in the market has become significantly easier in which deviations are well accounted for; this approach increases the overall success of these plans in the market. The leadership trends in the market are reinforcing the level of growth that can be achieved in the present market scenario. The alterations seen in terms of strategy execution and creation are altering the development pace of the market. The evolution patterns are revised in tandem to the customer likings to realize the greatest growth, and in the long run, viability. The framework for growth plans also has stimulated the market for potential new entrants. The market contenders are making considerable adjustments to minimize the incidence of competitive disadvantage. The market is also well equipped to meet the challenges and keep up with the dynamic growth trends effectively. The noteworthy competitors in the electrotherapy market are Eme srl (Italy), BTL (Czech Republic), EMS Physio Ltd. (UK), Medtronic (Republic of Ireland), Enraf-Nonius B.V.(Netherlands), Pure Care (US), gbo Medizintechnik AG (Germany), Phoenix Healthcare (UK), Omron Healthcare, Inc. (US), Walgreen Co. (US), STYMCO Technologies, LLC (US) and others

Electrotherapy Industry Updates:

Jan 2018 Omron lately introduced its first wireless at-home drug-free pain management device, Avail, which is an FDA-cleared TENS device designed to provide symptomatic relief and management of acute and chronic pain. Avail is fully wireless and uses two contoured pads that permits users to treat multiple pain sites simultaneously.

Chronic Disease Management Market 2021- 2025: Key Findings, Industry Segments, Profit Growth Analysis, Business Trends, Regional Study and Future Prospects

Chronic Disease Management Market Overview 

According to the report by Market Research Future (MRFR), the global chronic diseases management market size is predicted to reach a remarkable market valuation at a 17.50% CAGR over the forecast period.

The market is influenced by multiple driving factors such as the growing prevalence of chronic diseases such as diabetes, severe cardiovascular disorders, and others, along with the increasing demand for enhanced treatment methods. Additionally, rapidly advancing technologies l and increasing investments towards research and development activities taking place in the healthcare sector is expected to augment the scope of opportunities for market players.

Chronic Disease Management Market Segmental Analysis

The global market for chronic diseases management is segmented based on service types, application, deployment, and end-user.

Based on service type, the chronic diseases management market has been segmented into consulting service, educational service, implementation service, and others.

Based on application, the market for chronic diseases management has been segmented into asthma, cardiovascular, cancer, diabetes, stroke, and others.

Based on deployment, the chronic diseases management market has been segmented into cloud-based, on-premise, and web-based.

Based on end-user, the market for chronic diseases management has been segmented into payer and provider.

Chronic Disease Management Market Regional Analysis

Based on the region, the global chronic diseases management market has been segmented into the Americas (North and Latin America), Europe, Asia Pacific (APAC), and the Middle East and Africa.

The Americas account for the dominant region in the global chronic diseases management market and is slated to retain its leading market share over the forecast period. This has been accredited to the increasing prevalence of chronic diseases, and unhealthy lifestyles and diets of consumers in the region during the assessment period. Additionally, the high healthcare expenditure by the government to ensure superior quality medical facilities for consumers is also a contributing factor to the chronic diseases management market in the region over the review period.

Europe accounts for the second-largest region in the global chronic diseases management market and is likely to maintain its market standing over the forecast period. The increasing government support in the form of expenditure towards research and development activities is expected to drive the demand for chronic diseases management during the evaluation period.

The Asia Pacific has been assessed as the fastest growing region in the global chronic diseases management market. This is attributed to the increasing prevalence of chronic diseases in the region, along with growing demand for technologically advanced treatment methods, which creates a vast scope of opportunities for market players in emerging economies such as India, China, and Japan. The increase in government efforts to enhance the healthcare sector in the region is also expected to impact the market over the review period positively.

The Middle East and Africa region is accounted for the smallest market share through the forecast period, owing to the poor economic development, technological advancements, and political unrest in Africa. Nonetheless, increasing initiatives by governments and nonprofit organizations to provide primary medical facilities to consumers is assessed as a driving factor for the market over the evaluation period. The gradual, moderate growth of the market in the region is also attributed to the growing medical improvements and healthcare infrastructure in Middle Eastern developing countries such as Kuwait, Saudi Arabia, and the United Arab Emirates.

Obtain Premium Research Report Details @

Chronic Disease Management Market Key Players

The key players identified in the global chronic diseases management market are Allscripts Healthcare Solutions, Inc. (U.S.), AxisPoint Health (U.S.),  Epic Corporation Inc (U.S.), Harmony Information Systems, Inc. (U.S.), HealthSmart Holdings, Inc (U.S.), i2i Systems, Inc (U.S.), Infosys Limited (India), Pegasystems Inc. (U.S.), Phytel Inc (U.S.), TriZetto Corporation (U.S.), Wellcentive, Inc, (Georgia), Medecision, Inc (U.S.), ZeOmega Inc. (U.S.).

Chronic Disease Management Industry News

June 2019 – Houston Methodist researchers reported a successful drug delivery of two chronic disease medicines in the form of continuous, predetermined dosages with the use of a nanochannel delivery system (nDS) medical implant which was remote-controlled with Bluetooth technology.

June 2019 – Innomar Strategies, a leading healthcare service provider, launched a chronic diseases management platform called Chronically Simple for Canadian patients to register diagnostic images, medical records, and test results.

Glaucoma Surgery Market 2018-2023: Key Findings, Regional Study, Emerging Technologies, Business Trends, Industry Segments and Future Prospects

Glaucoma Surgery Market Scenario:

Glaucoma refers to a condition which causes blindness. It is a chronic and permanent disorder whose prevalence’s is increasing with increasing age. Beside this different diseases like diabetes and deficiency of vitamins can also cause this disease. The major driving factor for the growth of this Glaucoma Surgery Market size is increasing aging population across the globe and increasing the prevalence of diabetes. Changing lifestyle and unhealthy food has given a push for the growth of this market. On the other hand, preference of minimum surgery and the high cost of the surgical treatment can hamper the growth of the market.

Glaucoma Surgery Market Segmentation:

Glaucoma surgery market is classified as target as trabecular meshwork, suprachoroidal space and others.

According to surgery, the market is categorized as angle closure glaucoma surgery, laser surgery, aqueous shunt surgery, and other.

On basis of end user market segmentation includes hospital, ambulatory surgery centers and other.

Glaucoma Surgery Market Regional Analysis:

Geographic segmentation of glaucoma surgery market includes North America, Europe, Asia Pacific and Middle East and Africa regions.

With the expanding geriatric population and advancement in surgery technologies, North America glaucoma surgery market has been growing exponentially. Increasing expenditure on healthcare and improved infrastructure will impact the growth of the market. Europe has the second largest share in the glaucoma surgery market followed by Asia Pacific. A vast population of the region, especially that of the older generation as well as rapid development in healthcare sector has added impetus to the market.

Glaucoma Surgery Market Players:

Some of the players in the glaucoma surgery market include Novartis AG, Allergan, Merck & Co., Inc., Abbott, Akorn, Inc., Teva Pharmaceuticals, Bausch & Lomb, Pfizer, Santen, Carl Zeiss Meditec, Alcon, Ellex Medical Lasers, Lumenis, Topcon Medical Systems, Nidek, OPHTEC, Optos, Accutome, AqueSys, Canon, Essilor, Iridex Corporation etc.

Obtain Premium Research Report Details @

Glaucoma Surgery Industry News:

Recently BioMed, a commercial stage biotech company, announced that Mannin, the technology partner of BioMed, has won a UDS 7.5 million grant from the German state of Saxony. Mannin is a research-stage biotech company that aims on discovering, developing and commercializing therapeutics designed for vascular diseases. The grant is for funding of development of innovative treatments for glaucoma. With the grant, Q BioMed and Mannin can significantly accelerate research and development of therapeutic solutions.

In another recent move, ELT Sight, Inc. a company that focuses on long term microinvasive glaucoma surgery, announced that it has acquired the IP and assets of MLase AG excimer ophthalmic laser system. MLase is the manufacturer and marketer of novel laser systems, that include ExTra ELT Laser and disposable applicator used to perform implant-free, microinvasive glaucoma surgery.

Healthcare Contract Manufacturing Market 2021 Global Profit Growth Analysis, Size, Share, industry Segments and Business Trends by Forecast to 2023

Healthcare Contract Manufacturing Market Scope

The global healthcare contract manufacturing market had touched the valuation of USD 129.91 billion in 2016, estimates Market Research Future (MRFR). It is projected to attain a CAGR of 9.86% during the forecast period (2017–2023), Growth Drivers and Top Restraints

Growth Factors and Key Challenges

The data analysts opine that the worldwide healthcare contract manufacturing market size is expanding at a moderate but healthy rate. The chief factors backing the market growth include competition among companies with respect to the production and trade that favor CMO and the patent protection expiration of significant medical devices as well as drugs. Also, with both the contract manufacturers and clients reaping benefits and the agile form of manufacturing boosts market growth significantly.

Developing regions like Asia Pacific, Latin America and Middle East and Africa are experiencing potent growth of the biotechnology and pharmaceutical sectors. Several government bodies within these regions lend strong support in the form of numerous programs, conferences, initiatives as well as funding. The rapidly expanding pharmaceutical and biotechnology sectors lead to rise in demographic and economic growth along with surge in healthcare expenditures. On top of this, enhancement in the public-private healthcare funding has led to market growth in recent years. Therefore, developing areas across the globe are presumed to offer numerous growth opportunities to the healthcare CMO market in the following years.

The healthcare contract manufacturing market’s growth has been striking in the last few years owing to the numerous advantages offered by several international contract manufacturing companies. These companies offer a host of services to the pharmaceutical, medical device and biopharmaceutical companies. The pharmaceutical and biopharmaceutical companies enjoy numerous services by the CMO, whether it is the production of small amounts of materials for research and development (R&D) activities or huge funding for clinical study and commercialization.

Healthcare Contract Manufacturing Market Segmentation

The worldwide healthcare contract manufacturing market has been segmented on the basis of type, service type, and industry.

The type-wise segments are sterile and non-sterile. Non-sterile is believed to have the fastest growth rate of 10.0% from 2017 to 2023.

Depending on the service type, the market includes pharmaceutical contract manufacturing services, medical device contract manufacturing services.

The industries mentioned in the report are pharmaceutical, medical device, and biopharmaceutical.

Healthcare Contract Manufacturing Market Regional Analysis

Europe, Middle East and Africa, Asia Pacific and the Americas are the key markets for healthcare contract manufacturing.

The Americas has been identified as the leading healthcare contract manufacturing market, backed by high investment in healthcare and the presence of strong economy. The rising focus of research institutions on advancement of technology also benefits the regional market. Data experts note the rising focus of the contract manufacturers on the upgradation of their factories as well as manufacturing capabilities. As a result of cost-efficient models and advanced manufacturing units, the healthcare contract manufacturing market in the region is projected to expand considerably in the near future.

Europe is the second-most profitable market for healthcare contract manufacturing owing to the growing support from the governments and the high spending on healthcare. The Organization for Economic Co-operation and Development (OECD) reports that in 2014, the healthcare expenditure in Germany was around EUR 321 billion whereas France had the second highest healthcare expenditure of EUR 237 billion that year.

Growing at the fastest rate, Asia Pacific seems to possess lot of potential due to the high number of developing nations like India and China. These emerging economies are stimulating the growth of the healthcare contract manufacturing market, with the presence of highly developed healthcare infrastructure and the consistently advancing healthcare technology.

Middle East & Africa, with the least market share, lags behind due to less availability of medical facilities and poor development of the healthcare sector. But, countries like Kuwait and Qatar are striving to develop their medical facilities, which will have a positive impact on the overall regional market in the subsequent years.

Obtain Premium Research Report Details @

Healthcare Contract Manufacturing Market Key Vendors

The key vendors identified by MRFR include Lonza Ag, Catalant, Patheon, Mylan, Teva Pharmaceutical Industries, Benchmark Electronics, Vetter Pharma International, AbbVie, Boehringer Ingelheim, Aesica Pharmaceuticals, Grifols International, S.A, Hamilton Company, Sanmina Corporation, Flex Ltd, Forefront Medical Technologies, Evonik Industries to name a few.

Healthcare Contract Manufacturing Market Latest Developments

April 2019

Catalent will be acquiring Paragon Bio-services, a contract manufacturing organization with focus on viral vectors that are used in gene therapies, for the cost of USD 1.2 billion.

Create your website with
Get started